ОбзорГрафикНовостиTraderScreen

InspireMD Inc/  US45779A8466  /

IEX
11.11.2024  18:02:53 Изменение +0.02 Объем сделки Бид- Предложение21:16:01 Максимум Минимум
2.38USD +0.64% 172
Оборот: 406.25		 -Величина цены спроса: - 2.41Величина цены предложения: 177 2.38 2.36
GlobeNewswire 06.08 InspireMD Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 05.08 InspireMD Congratulates CREST-2 Investigators on Completion of Trial Enrollment
GlobeNewswire 30.07 InspireMD to Report Second Quarter 2024 Financial Results and Provide Corporate Business Update on T...
GlobeNewswire 01.07 InspireMD Announces Full Exercise of Series H Warrant Tranche for Gross Proceeds of $17.9 Million
GlobeNewswire 28.05 InspireMD Announces Presentation of Positive One-Year Follow-Up Results from the C-GUARDIANS U.S. In...
GlobeNewswire 14.05 InspireMD Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 07.05 InspireMD to Report First Quarter 2024 Financial Results and Provide Corporate Business Update on Tu...
GlobeNewswire 03.04 InspireMD to Present at the 23rd Annual Needham Virtual Healthcare Conference
GlobeNewswire 26.03 InspireMD Announces Abstract of One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational...
GlobeNewswire 06.03 InspireMD Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
GlobeNewswire 28.02 InspireMD to Report Fourth Quarter and Full-Year 2023 Financial Results and Provide Corporate Busine...
GlobeNewswire 12.02 InspireMD Appoints Principal Investigators for C-GUARDIANS II Clinical Trial of the SwitchGuard™ Neu...
GlobeNewswire 31.01 InspireMD Receives CE Mark Recertification Under EU’s New Medical Device Regulation (MDR) Regulatory...
GlobeNewswire 03.01 InspireMD Announces Appointment of Medical Technology Executive Pete Ligotti as Executive Vice Presi...
GlobeNewswire 20.12.2023 InspireMD Announces Issuance of Key U.S. Patent Covering Its SwitchGuard™ Neuroprotection System
GlobeNewswire 27.11.2023 InspireMD Announces Strategic Agreement with Jacobs Institute to Execute Early Feasibility Study of ...
GlobeNewswire 06.11.2023 InspireMD Reports Third Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire 02.11.2023 InspireMD to Participate in Upcoming November Investor Conferences
GlobeNewswire 01.11.2023 InspireMD Presents Positive 30-Day Follow-Up Results from the C-GUARDIANS U.S. Investigational Devic...
GlobeNewswire 30.10.2023 InspireMD to Report Third Quarter 2023 Financial Results and Provide Corporate Business Update on Mo...
GlobeNewswire 12.10.2023 InspireMD Supports CMS’ Final National Coverage Determination (NCD) Expanding Coverage of Carotid St...
GlobeNewswire 03.10.2023 InspireMD Announces Senior Leadership Changes to Support Commercial Growth Initiatives
GlobeNewswire 31.08.2023 InspireMD Announces Abstract of 30-Day Results from the C-Guardians U.S. Investigational Device Exem...
GlobeNewswire 16.03.2022 InspireMD to Host Key Opinion Leader Event on Carotid Artery Disease Management and Stroke Preventio...
GlobeNewswire 08.03.2022 InspireMD Reports Fourth Quarter and Year-End 2021 Financial Results